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Abstract
Background: The difficulty of directly measuring cellular dose is a significant obstacle to application of target
tissue dosimetry for nanoparticle and microparticle toxicity assessment, particularly for in vitro systems. As a
consequence, the target tissue paradigm for dosimetry and hazard assessment of nanoparticles has largely been
ignored in favor of using metrics of exposure (e.g. μg particle/mL culture medium, particle surface area/mL, particle
number/mL). We have developed a computational model of solution particokinetics (sedimentation, diffusion) and
dosimetry for non-interacting spherical particles and their agglomerates in monolayer cell culture systems. Particle
transport to cells is calculated by simultaneous solution of Stokes Law (sedimentation) and the Stokes-Einstein
equation (diffusion).
Results: The In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) was tested against measured transport
rates or cellular doses for multiple sizes of polystyrene spheres (20-1100 nm), 35 nm amorphous silica, and large
agglomerates of 30 nm iron oxide particles. Overall, without adjusting any parameters, model predicted cellular
doses were in close agreement with the experimental data, differing from as little as 5% to as much as three-fold,
but in most cases approximately two-fold, within the limits of the accuracy of the measurement systems. Applying
the model, we generalize the effects of particle size, particle density, agglomeration state and agglomerate
characteristics on target cell dosimetry in vitro.
Conclusions: Our results confirm our hypothesis that for liquid-based in vitro systems, the dose-rates and target
cell doses for all particles are not equal; they can vary significantly, in direct contrast to the assumption of dose-
equivalency implicit in the use of mass-based media concentrations as metrics of exposure for dose-response
assessment. The difference between equivalent nominal media concentration exposures on a μg/mL basis and
target cell doses on a particle surface area or number basis can be as high as three to six orders of magnitude. As
a consequence, in vitro hazard assessments utilizing mass-based exposure metrics have inherently high errors
where particle number or surface areas target cells doses are believed to drive response. The gold standard for
particle dosimetry for in vitro nanotoxicology studies should be direct experimental measurement of the cellular
content of the studied particle. However, where such measurements are impractical, unfeasible, and before such
measurements become common, particle dosimetry models such as ISDD provide a valuable, immediately useful
alternative, and eventually, an adjunct to such measurements.
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The rapid pace of introduction of new nanomaterials into
commerce, rising human exposure through consumer pro-
ducts, and the absence of reliable safety data or exposure
regulations [1] have raised risk assessment to a top priority
for stakeholders in the allied nanomaterial fields [2,3].
Complete animal-based safety testing of the virtually limit-
less number of potential engineered nanoparticles (ENPs)
and derivative microscale particles is widely recognized as
fiscally and temporally impossible. There are however,
promising data suggesting that the biological response to
ENPs can, for specific classes of materials, be related to
their structural and physicochemical properties [4-6], as
has been the case for classes of chemicals and pharmaceu-
ticals such as PCBs, Dioxins, and the statin drugs [7-9].
This work indicates there is an opportunity for a risk
assessment paradigm for ENPs that parallels the National
Research Council’s (NRC) vision for toxicology in the 21
st
century: the use of selected in vitro assays in cell culture
systems for hazard screening and development of quanti-
tative structure activity models, limited animal studies for
understanding kinetics, and the use of pharmacokinetic
models for extrapolation of results from in vitro to in vivo,
between species and across sensitive populations [10].
ENPs pose unique challenges to the NRC paradigm [11],
particularly in the area of dosimetry for in vitro systems
[12], where the science lags, and for extrapolation to and
between rodent test species and humans. Thus, there is a
critical need to develop a dosimetry-enabled framework
for ENP risk and hazard assessment.
The dose-response paradigm for the fields of pharmacol-
ogy and toxicology are predicated on the principle that
response is proportional to the concentration of the effec-
tor molecule at the site of action [13]. The use of target
tissue dose, rather than less specific measures of “dose”
such as exposure or administered dose, improves correla-
tions between dose and response for drugs, chemicals, and
inhaled gases and particles [14-17]. Target tissue dose has
become the gold standard for dose-response assessment in
pharmaceutical safety assessment and chemical risk assess-
ment [18], and was most recently used by National Insti-
tute for Occupational Safety and Health (NIOSH) to
conduct a risk assessment for nanoscale TiO2 [19].
Surprisingly, despite wide use of in vitro systems for
toxicity assessment of ENPs, the target tissue paradigm
for dosimetry has largely been ignored in favor of using
metrics of exposure, principally ENP concentration on a
mass, number, or surface area basis. Use of exposure
metrics, which are not reliable measures or proxies of
target cell dose across particle size or systems, may be
one root cause of the failure of in vitro systems to pre-
dict in vivo response, as reported by Sayes et al. [20],
and Warheit et al. [21]. Other factors, for example phar-
macodynamic differences or limitations of using a single
cell system to represent the integrated function of a tis-
sue, are also plausible confounders for in vitro-in vivo
predictions. Nonetheless, without a consistent, biologi-
cally relevant measure of dose to compare responses
across systems, in vitro systems cannot be expected to
represent dose-responses in vivo.
The definition of dose for nanoparticles in an in vitro sys-
tem is more dynamic, more complicated, and less compar-
able across particle types than it is for soluble chemicals.
Particles settle, diffuse and agglomerate at rates that differ
in relation to their size, density, and surface physicochemis-
try (reviewed in [12])(Figure 1). These particle properties
are expected to significantly affect cellular dose, but are lar-
gely ignored in the conduct of in vitro nanomaterial toxicity
studies. Limbach raised this issue [4], presenting experi-
mental evidence that transport to cells of 25-50 nm and
250-500 nm cerium oxide particles are different, depend-
ing in the former case on diffusion and the latter case on
gravitational settling. This differential transport was shown
to affect cellular uptake rates [4] and perhaps toxicity
[12,22]. Extending their analysis to include differences in
transport rates revealed that indeed particle dependent dif-
ferences in transport to cells from settling and diffusion
could significantly affect relative toxicity [12].
Most in vitro studies with nanomaterials would benefit
from direct measures of cellular dose. However, experi-
mental measurement of cellular dose in vitro (and
in vivo) is often difficult or costly, and as such, is a con-
siderable limitation of in vitro studies. Thus, measures
of target cell dose will often not be available to risk
assessors who must interpret published studies that
report particle characteristics and biological effects, but
not measures of cellular dose.
The dynamics of particles in liquids are well studied
and mathematical approaches for describing both dif-
fusion and gravitational settling have been developed
[23]. These approaches have yet to be formed into an
approach for describing the particokinetics–the com-
bined influence of diffusion and gravitational settling
on particle transport to cells in vitro.W eh a v ed e v e l -
oped a computational model of particokinetics (sedi-
mentation, diffusion) and dosimetry for non-
interacting spherical particles and their agglomerates
in a common cell culture system. ISDD is an in vitro
counterpart to the Multipath Particle Deposition
Model (MPPD) for inhaled particles [24]. The model is
developed from first principles–Stokes sedimentation
and Stokes-Einstein diffusion–and verified against
experimentally measured rates of nano- and micro-
particle transport across several particles sizes, and
densities as well as agglomerates.
ISDD provides the first computational in vitro target
cell dosimetry platform to improve the accuracy and
predictive power of in vitro systems for assessing ENP
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ers to design in vitro studies based on doses that directly
relate to probable human exposures based on target tis-
sue cell/dose comparisons. The model overcomes the
current absence of information on the comparative rates
and extent (e.g. dose) of nano- and micro-scale particle
transport to cells in culture.
Materials and methods
Model Development and Evaluation
Model Overview
In standard liquid-based cell culture systems, the amount
of particles associated with cells at any time is a function
of the rate of delivery of particles to the cells, how
strongly particles adhere to the cell surface, and the rates
of cellular uptake and loss by degradation or exocytosis.
ISDD applies well established, long-used principles of
diffusional and gravitational transport of particles in
viscous media to calculate the movement of particles
from the media to the bottom of a vessel where cells
reside. The net rate of transport downward toward the
bottom of the vessel is calculated within a single partial
differential equation, which is solved numerically to cal-
culate the fraction of material transported from media
to the bottom of the vessel. Simulations are conducted
using commonly available inputs for monodisperse par-
ticles: temperature, media density and viscosity, media
height, hydrodynamic particle size in the test media, and
particle density. Simulations of agglomerates also require
two additional parameters describing how the primary
particles are packed to form the agglomerate. The model
produces a time-course of particle surface area, number
and mass transported to the bottom of the vessel,
referred to as the delivered dose, which can be compared
to measured values in a cell free environment. The deliv-
ered dose can also be compared to measured amounts
Figure 1 Important Particle Transport Processes for In Vitro Systems. Depiction of the important processes and system characteristics
affecting particle transport rates in liquid containing in vitro systems. Transport of particles ≤ ~10 nm is controlled principally by diffusion, and
can become relatively fast at particle sizes less than 10 nm. Transport of particles greater than ~200 nm can also be relatively fast, particularly for
dense particles like the metals, and is controlled by sedimentation. Slower transport is expected to occur between 10 and 100 nm, where both
diffusion and sedimentation together control transport, but neither process is particularly effective.
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appropriate, but possibly less certain comparison because
the roles of cellular uptake, adherence, and loss of
adhered material during washing are not accounted for
explicitly in the current formulation of ISDD. ISDD
focuses on particle transport because this process can be
rate limiting, is very valuable for the experimentalist to
understand, can be simulated with a relatively small set
of easy to access parameters, and is independent of cell
type and other experimental conditions that affect cellu-
lar uptake. Moreover, at this time, it is experimentally
difficult to separate particle uptake (particles in a cell)
from cell associated particles (on a cell or in a cell). If
necessary, modifications to the boundary conditions or
assumptions regarding fractional uptake can be used to
account for cellular uptake. Thus, ISDD calculates the
delivered dose, which is equivalent to particles associated
with the cell (on a cell or in a cell), the only commonly
available experimental measure of target cell dose.
Derivation and Description of ISDD
The general dynamics of particles in viscous media are
well studied [25], and the mathematical basis for describ-
ing particle transport in liquids has been available for
more than 100 years [26]. Three primary processes trans-
port particles in static (non-flowing) uniform solutions
comprising the majority of liquid-containing cell culture
systems: diffusion, sedimentation, and advection (transfer
by motion of the fluid) [27]. In the formulation of ISDD,
we made the reasonable assumption that advective forces
in cell culture medium held at constant temperature, with-
out disturbance, are minimal and do not significantly
affect particle transport. More practically, diffusion and
sedimentation rates can be calculated from commonly
measured particle, culture medium, and experimental
design characteristics while the tools for experimentally
measuring advective forces on particles are not expected
to be widely available in biology labs. Particles, primary or
agglomerates, are assumed to be independent and non-
interacting (e.g. agglomerates do not form during the
simulation). The sides of the cell culture dish are not con-
sidered because at common media heights, the surface
area of the sides is very small relative to the bottom. Large
errors in model predictions would be evidence that one or
more of these simplifying assumptions may be wrong.
Stokes’ law defines the gravitationally driven sedimen-
tation rate (V, m/s) of particles in solution from the visc-
osity (μ, Pa·s) of the media, the relative densities (kg/m
3)
of the particle (rp) and fluid (rf), the diameter of the par-
ticle (d, m) and the acceleration due to gravity (g, m/s
2):
V
gd
18
pf
2
=
− () ρρ
μ
(1)
The Stokes-Einstein equation describes the relation-
ship between particle diameter and the rate of diffusion
(D, m
2/s) as a function of viscosity and temperature (T,
°K):
D
RT
3N d A
=

(2)
where R is the gas constant (L·kPa/K/mol) and NA is
Avogadro’s number.
The movement of particles through a fluid can also
give rise to fluid motion and turbulence. Generally, fluid
flow can be described by the Reynolds number, the
dimensionless ratio of inertial to viscous forces. Pro-
vided that the Reynolds number is below one, equations
1 and 2 define the only necessary terms in the convec-
tion-diffusion equation for laminar flow [28]. Reynolds
numbers for spheres less than 100 µm are less than one
[29]. Reynolds numbers were more than an order of
magnitude less than one for all particles, including
agglomerates, considered in this manuscript.
Mason and Weaver derived a mathematical solution to
the laminar convection-diffusion equation, a parabolic
partial differential equation (PDE) [23]:
∂
∂
=
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∂
−
∂
∂
n
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n
x
V
n
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2
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where t and x are the time (s) and distance (m)
dimensions, D and V are the previously defined diffusiv-
ity and sedimentation velocity (equations 1 and 2), and
n is the particle concentration. The particle concentra-
tion may be defined in any convenient units such as
particle number/mL or grams/mL. The first term on the
r i g h th a n ds i d eo fe q u a t i o n 3 describes the particle
motion by diffusion; the second describes the
sedimentation.
For initial conditions we assume a uniform particle
distribution at initiation of the experiment (equation
4a). The boundary conditions are, a) no particle flux
across the top of the media (equation 4b), and b) zero
concentration at the bottom (equation 4c), equivalent to
a condition where particles reaching the bottom and
adhering to cells no longer affect particle flux or con-
centration calculations (L = total media height):
a: n constant for all x, t 0
b: D
n
x
Vn at x L (top)
c: n 0 at x 0 (
0 ==
∂
∂
=
==
=
b bottom)
(4)
These boundary conditions can be modified for con-
sistency with experimentally measured boundary condi-
tions (e.g. non-uniform distribution of particles at the
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cells at the bottom). Thus, the in vitro dosimetry model
is a partial differential equation for dynamically simulat-
ing the transport of micro and nanoparticles in suspen-
sion in the vertical dimension (parallel to gravity).
To enable an efficient and stable computational solu-
tion, equation 3 was transformed into a dimensionless
form using the following dimensionless variables:
x
x
L
,t
tV
L
,
D
VL
,n
n
n0
== = = α (5)
which yields the transformed PDE and boundary con-
ditions used in the model code (a-c):
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2
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α
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(6)
The solution to equation 6 provides the means to
directly calculate the net movement of particles of dif-
ferent size and density in liquid media, i.e. cell culture
medium, to cells at the bottom of in an in vitro test sys-
tem. ISDD outputs the fraction, total number, surface
area and or mass of particles reaching cells at a given
time, which can be directly compared to measured
values in a cell free system (reaching the bottom of a
dish) or measured values of cell associated material
(adhered to or within cells). Along with input functions
for parameter values, equation 6 constitutes the model
for monomers. ISDD was developed in Matlab® (Math-
Works, Inc.), and is solved numerically using the PDE
solver in Matlab®. The model is available from the
authors upon request.
Most nanoparticles exist in some degree of agglomera-
tion in cell culture medium [30]. Agglomeration affects
particle shape, density and size, with corresponding
effects on both diffusion and sedimentation [12,30].
Because agglomerates are not necessarily composed of
efficiently packed particles, agglomerates are modeled as
having a fractal structure according to Sterling et al
[31]. The interparticle pore space in fractal agglomerates
comes from two sources: packing effects and the fractal
nature of the aggregate [31]. Both account for the
entrapment of media between particles in the agglomer-
ate (i.e. porosity) and the resulting reduction in density.
Packing effects are determined by the shapes of the
monomers and how they are packed into the agglomer-
ate. The fractal nature is determined by the flocculation
processes causing formation of the agglomerate [31].
The fractal nature of the agglomerate, represented by
the fractal dimension (1< DF <3), is generally more
important in determining density and porosity than the
packing factor (0< PF <1) [31]. Sterling used this fractal
description to effectively model the flocculation and
sedimentation of clay and colloidal silica agglomerates.
A fractal dimension of 3 reflects a perfect sphere with
little or no fractal structure and a porosity of zero (no
entrapped liquid). Similarly, a PF of 1 reflects the
absence of pore space in the agglomerate. In the
a b s e n c eo fa ne x p e r i m e n t a l l ym e a s u r e dP F ,av a l u eo f
0.637 for randomly packed spherical monomers reported
by Sterling was used [31]. The number of single parti-
cles per agglomerate (Np), agglomerate porosity (εagg,
unitless) and agglomerate density (ragg,k g / m
3)a r ec a l -
culated from the experimentally measured value of the
agglomerate diameter in media (dagg), and the primary
particle size and density, as described by Sterling: [31]:
a: d d
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b: 1
d
d
c: 1
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1
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The agglomerate sedimentation velocity can then be
related to the difference in density between the agglom-
erate and the media, as described by Sterling’s equation
15 [31]:
V
g
18
dd agg
agg f 3D F
agg
DF =
− () −− ρρ

1 (8)
This formulation of the sedimentation velocity equa-
tion reflects the assumption that liquid is entrapped in
the agglomerate pore space and that media does not
flow through the particle as it settles. The agglomerate
sedimentation velocity can be substituted into the con-
vection diffusion equation [31] (Equation 6) and solved
as previously described (also using dagg to calculate dif-
fusivity in Equation 2). This form of ISDD represents
the agglomerate simulation code. Like the monomer
code, it comprises a single PDE with supporting input
functions. Thus, ISDD accommodates simulating trans-
port of particles and agglomerates of a single size or as
size class distribution, as is typically reported by
dynamic light scattering (DLS) measurement.
Media Density and Viscosity
Viscosity measurements were performed using a
Cannon-Fenske opaque (reverse-flow) viscometer (Can-
non Instruments, State College, PA). Samples of Gibco
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between 0-10% percent fetal bovine serum were placed
in the viscometer and allowed to come to room tem-
perature for approximately 10 minutes. The kinematic
viscosity was calculated by multiplying the efflux time in
seconds by the viscometer constant. Samples were ana-
lyzed in quadruplicate. Dynamic viscosity (used in the
model) was calculated by dividing kinematic viscosity
(measured) by the media density (1.0 g/mL).
The density of DMEM+G media containing between
0-10% percent serum was determined by dividing the
weight of 100 mL (volumetric flask) of media by its
volume. Samples were analyzed in quadruplicate.
Particles
ISDD was verified against experimentally measured par-
ticle transport data for three different particles (polystyr-
ene, iron oxide, silica) from three independent studies
utilizing particles of different density, size and agglom-
eration state. Each study used a different method for
quantifying particle transport (see Kinetic Data). This
approach limits the potential for method-dependent
bias. Superparamagnetic iron oxide nanoparticles with a
manufacturer reported diameter of 30 nm (20 nm core
by transmission electron microscopy (TEM)), with ~10
nm polymer coating) were obtained from Ocean Nano-
technologies (Springdale, AS). Particle size was verified
by Dynamic Light Scattering (DLS) in MilliQ water and
RPMI media. DLS sizing was conducted using a custom
built high-sensitivity DLS instrument, enabling size-class
determination at low particle concentrations (10 μg/mL)
similar to those used in in vitro experiments. The
instrument is a modification of the instrument devel-
oped by our team [32], and its accuracy was verified
against polystyrene beads (Polysciences Inc, Warrington
PA, Cat# 16905). The original instrument was enhanced
by introducing optic fibers and avalanche photodiodes
to improve the collecting efficiency.
Carboxylated fluorescent polystyrene spheres with
manufacturer reported diameters of 24, 100, 210, 500
and 1100 nm in diameter were obtained from Invitrogen/
Molecular Probes. Particles were virtually monodisperse
in our experimental system (fluorescence microscopy, see
Particokinetic Data) and could be described according to
their reported primary particle size.
The amorphous silica nanoparticles used by Lison et al.
[33] to generate the cellular dose data simulated here had
a reported particle size of 29.3 nm (TEM) and a hydrody-
namic diameter of 34.8 nm in the study media, DMEM.
Particokinetic Data
Polystyrene Transport Rate Measurements
The time course of fluorescent polystyrene particles
reaching the bottom of 35 mm cell culture dishes (no
cells) was measured using time-lapse fluorescence
microscopy (Axiovert, Zeiss) at TIRF configuration, with
100× objective lens and 2× relay lens, leading to 200×
total magnification. Argon laser (Innova, Coherent) and
a nitrogen cooled CCD camera (Roper Scientific) were
used to excite the particles at 488 nm and acquire the
emission at 510-530 nm, respectively. Culture dish bot-
toms were coated with Poly-L-lysine to generate a posi-
tively charged layer to which the negatively charged
carboxylic acid surface modified polystyrene particles
would adhere to. For each particles size, 3 mL of tem-
perature equilibrated media containing 3.7 × 10
8 parti-
cles/mL was added to a dish and after a small delay
(~30 seconds) the culture dish was placed in the tem-
perature controlled (37°C) microscopy chamber and
sequential images were collected every 0.5 seconds for
500 seconds. The total number of particles transported
in the visual field of the microscope, 3,717 × 10
-5 cm
2,
was manually counted. The simulated number of parti-
cles was obtained by multiplying the calculated (ISDD)
fraction of particles settled by the total number of parti-
cles in the volume of media above the counting surface
(Concentration (3.7 × 10
8 particles/mL) × media height
(0.31 cm) × deposition surface area (3,717 × 10
-5 cm
2)):
4.26 × 10
3 particles
Iron Oxide Agglomerate Transport Rate Measurements
The rate of transport of large super-paramagnetic iron-
oxide particles to cultured RAW 264.7 macrophages was
measured under routine cell culture conditions (60 mm
plates, 3 mL serum free media, 37°C, subconfluent).
RAW 264.7 cells were seeded on 60 mm culture plates
and incubated overnight at 37°C in RPMI media supple-
mented with penicillin/streptomycin, 10% fetal bovine
serum, and L-Glutamine to reach estimated 80% con-
fluency. Media was then aspirated and cells were
exposed to 3 mL of serum-free media containing 2 μg/
mL of iron oxide nanoparticles. To ensure uniform mix-
ing and limit thermal convection, all exposure media
was first sonicated at 37°C for 10 minutes. Immediately
after the addition of dosing media, all cell cultures were
gently returned to the incubator. After 2, 4, and 8 hrs
the media was removed, cells were washed three times,
and harvested. For each exposure time, harvested cells
from three plates provided triplicate samples for dosi-
metry analysis, and one plate was utilized for counting.
Cellular iron oxide content was measured using a cus-
tom-built magnetic particle detector. The detector itself
is analogous to previous designs, and generally exploits
the nonlinearity of nanoparticle magnetization [34].
Because of its high sensitivity and ease of use, this type
of detector is of increased interest for different bioassays
that utilize magnetic labeling strategies [35-37]. The
same basic detection technology also serves as the basis
for a new imaging approach for measuring the amounts
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tissue [38,39]. Key to the current application is the
detection method’s high linearity (between measured
signal and nanoparticle amounts), and the fact that
detection results are independent of either tissue-type or
suspension media [40]. To calibrate our instrument a
standard curve was generated using the serial dilution of
stock nanoparticle suspensions and dosimetry data was
normalized to measured cell numbers to give the mass
of delivered nanomaterial per cell.
Published Silica Transport Data
Lison et al. [33] applied varying amounts (experiment A,
Figure Five A of their paper) or varying concentrations
(experiment B, Figure Five B) of 35 nm (DLS) spherical
amorphous silica to J774 cells cultured in 0.81 cm
2 wells
(48 well plate). Both experiments exposed cells to 90, 180,
270, 360 or 450 μL of media containing a constant particle
concentration, 37 μg/mL (experiment A) or a constant
particle mass, 16.7 μg (experiment B). The calculated cor-
responding media heights were 1.1, 2.2, 3.3, 4.4 and 4.5
mm. The media contained 10% fetal calf serum.
ISDD Simulations of Particle Transport
ISDD was exercised in accordance with the physical
characteristics of the experimental system and the parti-
cles. Measured particle hydrodynamic diameters, media
heights, temperature (37°C), media density (1.0 g/cm
3),
viscosity and particle concentrations were used. No
model parameters were varied to fit experimental data
on monodisperse particles (silica and polystyrene). The
fractal dimension (DF, Equation 7), the parameter
describing how efficiently the primary particles fill the
volume occupied by the agglomerate, was the only
unknown parameter for the simulation of iron oxide
agglomerates. Improbable values of DF, 1 (representing
a rod) and 3 (representing a perfectly filled sphere) were
not considered. Values near those reported for cerium
oxide and fumed silicon dioxide particles of “around 2”
[4,41] were varied to evaluate model behavior against
the experimental data.
The following parameters were the same for all simu-
lations: Temperature, 310°K; media density, 1.0 g/cm
3;
the media viscosity was 0.00069 Pa·s for all simulations
accept the simulation of the Lison et al. silica data [32],
which used a value of 0.00074 Pa·s to reflect the pre-
sence of serum proteins. Particle densities: polystyrene,
1.05 g/cm
3; amorphous silica, 2.2 g/cm
3); titanium diox-
ide, 4.23 g/cm
3;i r o no x i d e ,5 . 2g / c m
3; gold, 19.32 g/
cm
3. For agglomerates only: fractal dimension, 2.0-2.4,
packing factor 0.637. Particle sizes were those reported
in the material and methods section or in the results
section. Parameter values varied in other simulations are
provided in the appropriate figure legends.
Results
Media Characteristics
Media density was measured at different percentages of
serum so most standard cell culture systems could be
modeled in accordance with actual rather than assumed
media density. The density of media containing 0, 1, 2,
3, 4, 5, 6, 7, 8, 9, and 10% serum was measured. There
was no measureable increase in density with increasing
percent serum. The average media density across all
serum concentrations was 1.007 g/mL with a standard
error of 0.0001 g/mL and a range of 1.006-1.009 g/mL.
Media dynamic viscosity did change, however slightly,
as a function of serum concentration. DMEM+G has a
viscosity of 0.9598 Pa·s. DMEM+G with 10% serum has
a density of 1.011 Pa·s, approximating the viscosity of
water at room temperature (~ 1.0 Pa·s at 20°C). The dif-
ference between the viscosity of water and media con-
taining serum proteins was minimal (5%), indicating
that the dynamic viscosity of water, adjusted for tem-
perature (37°C for cell culture systems), can be used for
purposes of modeling particle transport in non-serum
containing media, with a modest increase of 5% for
media containing 10% serum.
Particle Characteristics
The iron oxide particles had a hydrodynamic diameter
of 34.8 nm in MilliQ water, consistent with the manu-
facturers reported nominal diameter of ~30 nm. In
RPMI media, the particles (10 μg/mL) were agglomer-
ated and polydisperse, with average agglomerate size of
993.7 (Std = 272.1). The size class distribution is pre-
sented in Figure 2. The amorphous silica nanoparticles
used by Lison et al. [33] to generate the cellular dose
data simulated here had a reported particle size of 29.3
nm (TEM) and a hydrodynamic diameter of 34.8 nm in
the study media, DMEM.
Model Evaluation
Parameter values used for ISDD simulations are pro-
vided in the methods section.
Diffusive transport of amorphous silica
To test ISDD for the diffusion driven region of the size
vs. transport curve, we compared ISDD calculated per-
cent of the administered dose delivered to cells in cul-
ture to the measured percent of administered dose
associated with cells after six hours exposure followed
by washing of cells [33] (Figure 3). In all cases ISDD
predicted a larger fraction of the administered dose
associated with the cells than was observed. Nonethe-
less, for most experimental conditions, there was good
agreement between modeled and observed cell asso-
ciated silica: the difference between modeled and
observed silica was approximately two-fold, which may
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remaining post washing, incomplete confluency of the
cell monolayer, or low media volume effects on cellular
function, particularly uptake of particles. The greatest
difference between measured and calculated cell asso-
ciated silica was, approximately six-fold, was observed
for the low volume experiments where the media height
was small (1.1 mm). Given the expectation that the
transport processes are the same in all the experiments,
it is not immediately clear why there is poorer agree-
ment between measured and calculated silica doses for
the 90 μL volume experiments. It is plausible that the
more limited buffering capacity of the lower volume
affected cellular function, particularly the ability to pha-
gocytose particles. Alternatively, the more rapid build
up of secreted factors (e.g. cytokines) in the smaller
media volume could also impact cellular uptake of parti-
cles in a non-intuitive fashion through feedback loops. It
is noteworthy that ISDD predicts a steadily increasing
amount of particles as media height (volume) decreases,
but experimental measurements of cell associated mate-
rial made by Lison et al. [32] are roughly unchanged by
media volume and height. The modeled trend is
consistent with expectations: at extremely low volumes
and media heights, all particles would be in immediate
proximity to cells and be delivered rapidly and more
completely, whereas at large volumes and media heights,
only a fraction of particles would reach cells over the
course of an experiment. Because cell associated silica
was relatively constant across all experiments, where
total particle number and media heights varied, it is also
plausible that the uptake of particles by cells in the
experiments by Lison et al. [33] was saturated at the
tested particle exposure levels.
Transport of nano and micron sized polystyrene spheres
Transport rates of carboxylated polystyrene particles 24,
100, 210, 500 and 1100 nm in diameter were experi-
mentally determined using time-lapse fluorescence
microscopy (Axiovert, Zeiss) at TIRF configuration. For
these constant particle number exposures, measured
rates of particle transport varied approximately two-fold
across particle sizes (Table 1). In comparison, modeled
transport rates varied approximately three-fold with the
highest transport rate predicted for the 20 nm particles,
consistent with their rapid diffusional transport. Gener-
ally, there was good correspondence between measured
Figure 2 Size Class Distribution Data for Iron Oxide Particles. Size class distribution of iron oxide particles measured by high sensitivity DLS.
Columns represent number fractions. The line represents the cumulative number fraction.
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measured as the ratio of simulated to measured rates of
transport varied from 0.37 to 0.51, a factor of 2-3.
Sedimentation of large iron oxide agglomerates
The rate of transport of agglomerates of ~30 nm iron
oxide particles was experimentally determined by mea-
suring the amount of cell associated iron oxide in
RAW 264.7 cells after 2, 4 and 8 hours of exposure.
The standard curve for the magnetic particle detection
system was highly linear across two orders of magni-
tude (Figure 4).
Transport of the polydisperse solution of agglomerates
was modeled as a mass weighted distribution of particles
in accordance with the particle size and number fraction
associated with each agglomerate size class (Figure 2): The
total mass of iron oxide delivered at each time step was
calculated as the sum of calculated mass (fraction deliv-
ered times mass in the experiment) of each of the five
Figure 3 Simulated Silica Dose. Comparison of observed and ISDD simulated fraction of administered dose associated with cells in culture
exposed to varying amounts and concentrations of 35 nm amorphous silica nanoparticles in media with heights varying from 1.1-4.5 mm. Gray
bars represent measured values reported in two experiments reported by Lison et al. (2008)[32] in their Figure 5A and 5B.
Table 1 Comparison of observed and simulated transport rates of carboxylated polystyrene particles
Particle Diameter (nm) Transport Rate Particles/500 seconds Simulated/Observed
Observed
1 Simulated
24 190 181 0.95
100 196/155 89 0.51
210 101/140 63 0.52
500 96/130 73 0.65
1100 140/200 62 0.37
1 Results from two experiments shown
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dimension (DF) of the iron oxide agglomerates was not
known. Improbable values of DF, 1 (representing a rod)
and 3 (representing a perfectly filled sphere) were not con-
sidered. Values near those reported for cerium oxide and
fumed silicon dioxide of “around 2” [4,41] were considered
plausible. Accordingly, DF was varied between 2.0 and 2.4,
to evaluate model behavior against the experimental data.
For this range of plausible values of DF, ISDD calculated
delivered iron oxide was in close agreement with mea-
sured values of cell associated iron oxide (Figure 5), differ-
ing at most by a factor of approximately 2 or less.
Correspondence between observed and model calculated
transport of iron oxide was greatest, differing by only 5-
3 0 % ,f o raD Fo f2 . 3 .O ft h ev a l u e so fD Ft e s t e d ,2 . 3w a s
the most plausible value, consistent with the limited infor-
mation available on DF for metal oxide particles. The for-
mulation of the sedimentation velocity used in ISDD is
one of two forms cited by Sterling [31]. The alternative
formulation (Sterling [31], Table 1) assumes that media
can flow through the agglomerate and uses the density of
the primary particle rather than the density of the
agglomerate. Resulting sedimentation rates would be 3-4
times faster than we observed experimentally for iron
oxide particles and we therefore elected not to use this
form of the aggregate sedimentation rate equation.
Generalized Affect of Media Height, Particle Size and
Density on Delivered Dose for Submicron Particles
Of the commonly varied experimental conditions or parti-
cle characteristics, media height, particle density, particle
size, and agglomeration state are expected to have the
greatest impact on the rate and extent of nanoparticle and
microparticle transport, and thus delivered dose to cells
in vitro. Using ISDD, the impact of these parameters on
target cell dosimetry can be described quantitatively, pro-
viding a clearer portrait of the importance of these pro-
cesses to both experimental design and interpretation.
Specifically, these descriptions quantify the errors asso-
ciated with ignoring the kinetics of particles in solution
when conducting toxicity or dose-response studies.
Particle size and density
When the toxicity of nanoparticles or microparticles of
different density and size are assayed in vitro using
Figure 4 Iron Oxide MPD Standard Curve. Standard curve for analysis of iron oxide nanoparticles in RAW 264.7 macrophages showing linear
responses across a more than 100 fold increase in particle mass.
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mL), there are two factors which, depending on the
dose metric of interest, may result in significant differ-
ences in target cell doses for each particle. First, the
same nominal mass media concentration represents dif-
ferent particle numbers and different surface areas for
each particle. Secondly, each particle may have a differ-
ent transport rate. There is therefore no simple, consis-
tent relationship between nominal particle exposures on
a mass basis in vitro, and the corresponding cellular
doses on a mass, surface area or particle number basis.
This relationship is illustrated in Figure 6 which shows
the ISDD-calculated cellular dose of particles across size
and density (polystyrene to gold) on a particle mass,
particle surface area, and particle number basis. To
demonstrate the integrated effects of different transport
rates on target cell doses, the time weighted target cell
dose (area under the curve - AUC) was calculated using
ISDD for a 10 μg/mL (3 mL media) exposure over a 24
hour exposure period (Figure 6). On a particle number
basis, the target cell AUC varies six orders of magnitude
across particle size and density (Figure 6A). On a sur-
face area basis, the most commonly cited relevant
metric of dose, target cell doses vary three orders of
magnitude across particle size and density and approxi-
mately one order of magnitude between particles of the
same size but different density (Figure 6B). A plot of the
target cell dose on a particle mass basis shows smaller
differences between particle of the same size and across
particle size and density, but shows the expected
U-shape for the effects particle size arising from the
interplay between diffusive transport and sedimentation
(Figure 6C). These differences in dose arise from differ-
ences in the rate and extent of particle transport over
the duration of the experiment. Figure 7 shows the time
course for particle transport for different sizes of TiO2,
a representative metal oxide. The principle holds for
particles with different densities.
Figure 5 Simulated Transport of Iron Oxide Agglomerates. Comparison of the modeled and observed transport kinetics of iron oxide
agglomerates to RAW 264.7 macrophages. Particle transport was modeled for plausible values of the agglomerate fractal dimension (DF); a DF
of 2.3 provided the best correspondence between modeled and observed data. Error bars (visible only on one point) for experimental data
reflect standard deviations. The media height was 1.06 mm in this experiment.
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Page 12 of 20Figure 6 Particle Size and Density Effects on Target Cell Dose. Target cell doses calculated using ISDD for cells exposed 24 hours in vitro to
10 μg/mL (3 mL, media height 3.1 mm) of particles with different sizes and densities. Panels A, B and C present target cell AUC on a particle
number, surface area and mass basis.
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estimated doses and experimentally measured cell dose
across a wide range of particles with disparate size and
density are quite small. Thus, ISDD supports compari-
son of biological response across diverse particles sizes
and density by providing an accurate estimate of deliv-
ered dose.
In contrast, the difference between assumed dose
based on equivalent exposures as μg/mL and the deliv-
ered dose can be several orders of magnitude when par-
ticles with different densities and sizes are compared.
Two factors contribute to the sometimes very large dif-
ferences (a) differences in size- and density-dependent
transport rates and (b) differences in the number and
surface area of particles per unit mass particle concen-
tration. When particles of a similar size and density are
compared, transport related effects on delivered dose
may be small: 2-10 fold unless confounded by agglom-
eration. However, when the cellular dose for particulates
of different size and density is assumed to be equivalent
based on equivalent exposures (media concentration),
the difference between assumed and actual delivered
doses can differ by one to six orders of magnitude.
ISDD offers significant advantages over the use of mass
based metrics of nanomaterial exposure or assumptions
of dose-equivalency based on metrics of exposure (e.g.
μg/mL) for dose-response assessment.
Media height
Media height above cells in culture determines the dis-
tance particles must travel to reach cells and the total
number of particles available for transport to cells. Parti-
cles distributed evenly at the start of an in vitro experi-
ment will have a distribution of distances to travel (i.e.
zero to media height), and a corresponding distribution
of times to reach cells. At commonly used media heights
(1-10 mm) and study durations (~24 hours), particle
transport is neither constant nor fast enough to be non-
limiting; rather, transport times are on the order of
Figure 7 Transport Rates for TiO2. ISDD calculated fraction of nano and micron scale TiO2 particles delivered to cells over the duration of a 24
hour in vitro study with a media height 3.1 mm. Different rates of particle transport result in different time-courses for delivery to cells, which is
only complete for large particles by 24 hours.
Hinderliter et al. Particle and Fibre Toxicology 2010, 7:36
http://www.particleandfibretoxicology.com/content/7/1/36
Page 14 of 20hours, similar to the duration of in vitro studies. For
example, the extent of transport TiO2 particles 10-500
nm in diameter varies significantly with media height
(Figure 8). An unexpected consequence of this relation-
ship is that linear increases in total administered dose
introduced through linear increases in media volume
(constant concentration) bring a linear increase in
media height, and consequently, a linear increase in the
average distance a particle must travel to reach the cells.
But, because the time to diffuse any distance is a func-
tion of the distance squared (Equation 6) [12,23], the
linear increase in media height results in a quadratic
increase in the transport time and non-linear–and at
some media heights, saturating–transport of particles to
the cells. Thus, increasing media volume and adminis-
tered dose do not necessarily yield equivalent increases
in target cell dose. Moreover, differences in media
height alone between studies can confound comparisons
of dose-response data.
Agglomeration state
Agglomeration and aggregation of particulates in high
ionic strength aqueous solutions such as cell culture
media is common. Formation of large agglomerates
increases the size and mass of particles in proportion to
the number of particles in the agglomerate. Due to the
entrapment of media within the open volume of the
agglomerate, the density of an agglomerate is generally
less than that of the primary particle. The parameter
DF, the fractal dimension, describes the space filling effi-
ciency of agglomerate (EQ 7) and along with the pack-
ing factor (PF, EQ 7), determines the density of the
agglomerate. Thus, agglomeration dependent changes in
mass, size and density all effect changes in the rates of
agglomerate diffusional and gravitational transport.
To demonstrate the importance of considering forma-
tion of agglomerates to target cell dosimetry, ISDD was
used to simulate the transport of agglomerates of 1-
10,000 primary 34.6 nm Fe2O3 particles over a period of
Figure 8 Media Height Effects on the Extent of Transport. ISDD calculated fraction of nano- and micron scale TiO2 particles delivered to cells
over the duration of a 24 hour in vitro study as a function of media height. Increases in media height reduce the fraction of the administered
dose reaching cells, particularly for nanoparticles, where diffusion drives transport.
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simulations were conducted for a fractal dimension of
2.2 or 2.4, the approximate range of DF determined in
our simulations (Figure 9). Increasing the number of
primary particles in a Fe2O3 agglomerate from 1 to
10,000 particles only increases sedimentation rates if
their space filling efficiency is high (e.g. DF = 2.4, Figure
9B). Sedimentation rates decrease with agglomerate size
when packing is less efficient (Figure 9A, DF = 2.2).
These changes in the extent of sedimentation result
from reduced agglomerate density.
Reductions in agglomerate density from inefficient
packing can be significant, particularly where agglomer-
ates are composed of a large number of primary parti-
cles (Additional File 1) or DF is large (Additional File
2). Large particles with a loosely packed structure can
approach a density nearing that of the media as the
volume and mass of trapped media dominates the total
volume and mass of the agglomerate. Fractal dimensions
between 2 and 2.5 are consistent with inefficient or
moderately efficient space filling and agglomerates with
a density significantly reduced from that of the
monomer.
The relationship between agglomerate size, density
and effective sedimentation rates depends on many fac-
tors (see EQ 7) and is therefore unique to each particle
and exposure environment. The examples here demon-
strate the potential effect and importance of agglomera-
tion on particle dosimetry, but should not be applied to
particles or systems different from the examples pre-
sented here.
Discussion
Driven by wide recognition that target tissue (or cell)
dose is the most appropriate metric of dose for risk and
safety assessment, there has been continued growth in
the development of computational tools for estimating
target tissue dose in vivo for a wide range of materials:
volatile and non-volatile materials [42-44] organic che-
micals [45,46], pharmaceuticals [47,48], and particulates
and ultrafine particulates [49-53]. It is surprising, then,
given the growing importance of in vitro studies to che-
mical and particle risk assessment [10] that few efforts
[43,54-56] have been directed at developing computa-
tional models of dosimetry for in vitro systems. In part,
this oversight may be the result of the incorrect belief
that in contrast to in vivo,t h e r ea r en oi m p o r t a n t
kinetic or other processes to consider when addressing
the issue of target tissue dose in vitro.W eh a v es h o w n
this assumption is not universally true for chemicals
[54] and particulates, including nanomaterials [12].
Thus, as with other systems where kinetics influence
dose, there is a need for computational models of
in vitro nanoparticle and microparticle target tissue
dosimetry to supplement experimental measurements or
extrapolate across particle type and experimental
systems.
ISDD is a computational model of particokinetics
(sedimentation, diffusion) and dosimetry for non-inter-
acting spherical particles and their agglomerates in
monolayer cell culture systems. Through simulation,
ISDD calculates the delivered dose and rate of transport
of particles in vitro using readily available parameters
(temperature, media height, particle size in solution,
agglomeration state and particle density). To our knowl-
edge this is the first computational model extending
principles long used to calculate particle deposition in
the respiratory tract to a simpler system: static liquid
in vitro studies. Application of ISDD opens the door for
post-hoc interpretation of published studies, scaling
across particle types and doses and development of a
more predictive paradigm for nanoparticle in vitro
studies.
Figure 9 Agglomerate Fractal Dimension Effects on Transport.
ISDD calculated rate of transport over a 24 hour in vitro exposure
fto Fe2O3 agglomerates with, a primary particle size of 34.6 nm, and
a fractal dimension of 2.2 (A) or 2.4 (B). The media height was
3.1 mm. Each line represents a different number of particles per
agglomerate. Increasing the size and mass of agglomerates
decreases diffusion rates, but may not increase sedimentation rates.
For more efficiently packed agglomerates (DF = 2.4, bottom panel),
but not less efficiently packed agglomerates, increases in
agglomeration size can increase the rate and extent of
sedimentation.
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ISDD simulated particle transport of monodisperse silica
and polystyrene particles corresponded very well with
measured transport, differing in most cases by a factor
of approximately two or less. This level of accuracy is
common to more sophisticated, extensively calibrated
models of in vivo pharmacokinetics used in risk assess-
ment, such as physiologically based pharmacokinetic
(PBPK) models [46,57,58]. There cannot be an expecta-
tion that model accuracy is greater than limits imposed
by experimental and biological variability, which can be
significant. Thus, PBPK and other biokinetic models are
commonly considered acceptable and useful if outputs
are within a factor of approximately two (or sometimes
more) of the data and the dose and time trends (model
behavior) are consistent with experimentally measured
trends. This general level of error can be compared to
the other sources of error inherent in assuming mass
media concentrations are, alone, sufficient measures of
exposure to comparative toxicity studies for particles: 1)
size and density differences in transport rates, approxi-
mately 2-10 fold; 2) media height differences in fraction
of material transported to cells, up to approximately 10
fold; 3) particle size and density dependent differences
in the number and surface area of particles per unit
concentration (e.g. 1 μg/ml), 1,000-1,000,000 fold. Thus,
the error in ISDD is low relative to the potential errors
associated with common assumptions applied to most
in vitro particle toxicity studies.
Beyond the accuracy issue, ISDD allows users to
explore expected trends in delivered dose to determine
if delivery processes are potentially important. For
example, ISDD predicted a six-fold increase in trans-
port of 35 nm amorphous silica as media heights were
reduced from 4.5 mm to 1.1 mm, but measured cell
associated silica was relatively constant [33]. The
experimental finding could be the result of either con-
stant transport rates, or one or more other experimen-
tal factors affecting cellular uptake such as saturated
uptake of silica. For example, it is plausible that lower
levels of nutrients may have affected cell function,
uptake of particles, or the number of cells. Since ISDD
shows that significant differences in particle transport
and delivered dose are expected, we arrive at the
hypothesis that cellular uptake might be saturated.
Arriving at this insight, and the experimentally testable
hypothesis it produces, is not feasible if the experimen-
talist is unaware of differences in particle transport
under the experimental conditions or incorrectly
assumes static particle concentration is all one needs
to know for dose-response assessment.
With calibration of the parameter DF, ISDD also
simulated the transport of a dispersion of more compli-
cated agglomerates of 30 nm iron oxide particles,
providing greater confidence that the generalization of
particle transport represented by the model can be
widely applied to nanoparticle and microparticle solu-
tions including agglomerates. Large errors in model pre-
dictions were not observed, with one exception (low
volume, silica transport experiment), providing good evi-
dence that one or more of the simplifying assumptions
used in the formulation of the model were not violated.
There are additional published experimental data that
support the general accuracy of ISDD. Limbach and
Stark were the first to carefully explore the relationship
between particle size and delivered dose to cells in vitro,
firmly and convincingly establishing that particle size
and agglomeration state has a significant impact on
dose to the cell [4]. Using ceria particles with mean dia-
meters of 20-50 nm or 250-400 nm they exposed lung
fibroblasts and measured ceria content by ICP-MS at
6-10 times over the 300 minute experiment. Comparing
cellular ceria content and calculated ceria transport
rates they showed that cellular ceria uptake of 20-50 nm
particles was consistent with diffusion limited transport,
and uptake of 250-400 nm particles was primarily con-
trolled by sedimentation. They also showed that for a
constant nominal mass media concentration the mass of
ceria in cells was related to particle size, with greater
mass amounts of ceria but smaller surface area and
number concentrations found in cells exposed to larger,
more rapidly sedimenting particles. The authors con-
cluded that particle size was the most important factor
determining the amount of material on or in cells and
that particle concentration and total surface area were
of “minor” importance. Limbach and Stark’s findings [4]
demonstrate the appropriateness of the Stokes-Einstein
equation for predicting transport in vitro,a n dt h e
importance of addressing these transport issues in vitro
nanomaterial toxicity studies.
These findings were further verified by Sun et al. [59],
in an elegant quantitative study of in vitro transport and
uptake of fluorescently labeled 100 nm mesoporous
silica nanoparticles in human lung cancer cells. The
movement and uptake of particles was observed using
differential interference contrast microscopy. Transport
to the cell through the cell culture media was driven by
diffusion. The diffusion rate calculated directly from
measured rates of particle movement was 2.9 × 10
-8
cm
2/s, in very close agreement with the theoretical value
calculated from the Stokes-Einstein equation as applied
in ISSD: 4.4 × 10
-8 cm
2/s [59]. Not surprisingly, the dif-
fusion rate slowed an order of magnitude as the nano-
particles neared the cell surface. It should also be noted
that the most common approach to measuring particle
size, DLS, directly measures the diffusivity of particles in
solution and infers the size of the particle using the
Stokes-Einstein equation. Thus, it would seem, that if
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that the ISDD calculated diffusional transport rate is
accurate should follow. Finally, we point out that the
description of particle motion in liquids derived by
Navier, Stokes and Einstein and applied in ISSD has
been widely and successfully applied across multiple
scientific and engineering disciplines for many decades.
There are, however, a number of limitations to be
considered when using ISDD. Particle settling must not
generate turbulence (low Reynolds numbers) and
dynamic agglomeration or other particle interactions are
not accounted for in the model. The model may not be
appropriate to apply where advection occurs in the cell
culture system or where there has been significant
advective or mechanical mixing over the course of the
experiment. Formulated for spheres or particles that can
be adequately described as spheres, ISDD should not be
used for fibers without additional modification and test-
ing. Changes in the agglomeration or aggregation state
of modeled particles would be expected to lead to larger
discrepancies between modeled and observed target cell
doses. Uncertainty in many of the parameters for the
model is low; particle size, density, agglomeration state
and media temperature and viscosity are easy to mea-
sure with sufficient accuracy. As noted, the PF and DF
are more challenging to obtain experimentally, and
represent an area of higher uncertainty. Nonetheless,
ISDD provides an excellent approximation of the
expected cellular dose as a function of particle size and
density, and allows reasonable estimates of the range of
errors introduced using metrics of exposure.
ISDD, now tested and verified, provides further quan-
titative evidence that use of nominal media concentra-
t i o na sam e t r i co f“dose”–its actually exposure–
confounds particle comparisons by introducing large
errors from the assumption that dose to the target cell
or site is proportional to media concentration across
particle size, density, and agglomeration state. This erro-
neous assumption is particularly important where nom-
inal mass media concentrations (μg/mL) are used for
dose response analysis, but the biologically relevant
dose-metric is target cell dose on a surface area or parti-
cle number basis. In this case, particle size and density
dependent differences in transport rates are com-
p o u n d e db yp a r t i c l es i z ea n dd e n s i t yd e p e n d e n td i f f e r -
ences in particle number and surface area. Of course,
this problem is somewhat mitigated by using nominal
surface area concentrations in dose-response experi-
ments. These conclusions, along with those regarding
the influence of media height and agglomeration status
on particle transport reaffirm the need for a far greater
curiosity about target cell dosimetry in vitro and a cor-
respondingly increased role for research on nanoparticle
dosimetry for in vitro systems.
The value of organizing and conceptualizing the pro-
cesses controlling particle transport and dosimetry in
cell culture systems and presenting them in the form of
a model to the community of biologists and other scien-
tists using in vitro systems should not be overlooked. In
the past, similar efforts such as the early publications on
PBPK modeling and more recent biologically based
dose-response (BBDR) models have led to a deeper and
wider understanding of the systems being studied,
enabled new biological or toxicological insights, and
promoted more accurate study design and interpreta-
tion. Experimentalists can use ISDD to explore the
potential impact of particle and media characteristics on
target cell dose in their systems, and to guide experi-
mental design. Hazard and risk assessors can utilize the
model for post-hoc calculation of target cell doses from
published studies. As more complete models of biologi-
cal response to particles are developed, linkages to ISDD
will allow inclusion of target cell dose-time vectors,
improving the basis for biologically-based dose response
analysis and predictive toxicology. Perhaps most impor-
tantly, the concepts represented by the ISDD model can
be used to define a new paradigm for nanomaterial and
particle dosimetry for in vitro systems that parallels the
widely accepted paradigm for particle dosimetry in vitro.
Absent now, such a paradigm would improve the accu-
racy and scalability of in vitro systems for hazard screen-
ing and exploratory mechanistic work.
The gold standard for particle dosimetry for in vitro
nanotoxicology studies should be direct experimental
measurement of the cellular content of the studied par-
ticle. However, where such measurements are impracti-
cal, unfeasible, and before such measurements become
common, particle dosimetry models such as ISDD pro-
vide a valuable, immediately useful alternative, and even-
tually an adjunct to such measurements. The model also
allows researchers to estimate trends in particle trans-
port to determine if transport processes may be an
important factor in the study. Ultimately, ISDD is a
computational framework for describing particle trans-
port that can raise awareness of particokinetic issues in
vitro, and be revised to improve its accuracy for specific
particles and linked to models describing cellular pro-
cesses affecting uptake of particles.
Additional material
Additional File 1: Figure S1: Agglomerate density as a function of
the number of monomers in the particle. This file contains a graph of
the density of agglomerates as a function of the number of monomers
within the agglomerate.
Additional File 2: Figure S2: Agglomerate density as a function of
the agglomerate fractal dimension. This file contains a graph of the
density of agglomerates as a function of the fractal dimension of the
agglomerate.
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